Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015–2020

Oliver Van Oekelen; Nicole Birrer; William Wesson; Vincent L. Galate; Edward R.Scheffer Cliff; Aaron M. Goodman; Al Ola Abdallah; Rajshekhar Chakraborty; Vinay Prasad; Ghulam Rehman Mohyuddin

doi:10.1038/s41408-022-00750-1

Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015–2020

Oliver Van Oekelen, Nicole Birrer, William Wesson, Vincent L. Galate, Edward R.Scheffer Cliff, Aaron M. Goodman, Al Ola Abdallah, Rajshekhar Chakraborty, Vinay Prasad, Ghulam Rehman Mohyuddin

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English
Article number	155
Journal	Blood Cancer Journal
Volume	12
Issue number	11
DOIs	https://doi.org/10.1038/s41408-022-00750-1
State	Published - Nov 2022

Access to Document

10.1038/s41408-022-00750-1

Cite this

@article{1e6e2fee79254ba1b3f5d3e24e89c72b,

title = "Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015–2020",

author = "{Van Oekelen}, Oliver and Nicole Birrer and William Wesson and Galate, {Vincent L.} and Cliff, {Edward R.Scheffer} and Goodman, {Aaron M.} and Abdallah, {Al Ola} and Rajshekhar Chakraborty and Vinay Prasad and Mohyuddin, {Ghulam Rehman}",

note = "Funding Information: Authors declare no conflict of interest other than the following: AMG reports consulting for Seattle Genetics and EUSA Pharma. VP reports research funding from Arnold Ventures, royalties from Johns Hopkins University Press, consulting fees from United Health Care, and honoraria from EviCore. ",

year = "2022",

month = nov,

doi = "10.1038/s41408-022-00750-1",

language = "English",

volume = "12",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "11",

}

TY - JOUR

T1 - Characteristics of measurable residual disease assessment in myeloma

T2 - a review of clinical trials from 2015–2020

AU - Van Oekelen, Oliver

AU - Birrer, Nicole

AU - Wesson, William

AU - Galate, Vincent L.

AU - Cliff, Edward R.Scheffer

AU - Goodman, Aaron M.

AU - Abdallah, Al Ola

AU - Chakraborty, Rajshekhar

AU - Prasad, Vinay

AU - Mohyuddin, Ghulam Rehman

N1 - Funding Information: Authors declare no conflict of interest other than the following: AMG reports consulting for Seattle Genetics and EUSA Pharma. VP reports research funding from Arnold Ventures, royalties from Johns Hopkins University Press, consulting fees from United Health Care, and honoraria from EviCore.

PY - 2022/11

Y1 - 2022/11

UR - http://www.scopus.com/inward/record.url?scp=85141853703&partnerID=8YFLogxK

U2 - 10.1038/s41408-022-00750-1

DO - 10.1038/s41408-022-00750-1

M3 - Letter

C2 - 36379917

AN - SCOPUS:85141853703

SN - 2044-5385

VL - 12

JO - Blood Cancer Journal

JF - Blood Cancer Journal

IS - 11

M1 - 155

ER -